Clinical implications of cytogenetic abnormalities in melanoma

Mark A Nelson, F. H. Thompson, J. Emerson, M. Aickin, L. Adair, J. M. Trent, S. P L Leong, R. Taetle

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Unlike leukemia, in which specific reciprocal translocations are frequently observed, melanomas involve complex recurring chromosome anomalies. Analysis of the constituted genome of melanoma patients should identify cancer susceptibility genes and at-risk individuals in families with a history of melanoma. The first of these genes to be cloned is the cell cycle regulatory protein inhibitor-the p16 gene-and a second gene locus for melanoma predisposition has been linked to the chromosome 1p36 band region. Detection of the most common somatic genetic alterations in melanoma enhances our understanding of molecular mechanisms of melanoma development and may lead to genetic markers in melanoma. Some alterations may be used to identify interesting subpopulations. Others may be of prognostic value when they are considered in tandem with clinical data.

Original languageEnglish (US)
Pages (from-to)1257-1271
Number of pages15
JournalSurgical Clinics of North America
Volume76
Issue number6
DOIs
StatePublished - 1996

Fingerprint

Chromosome Aberrations
Melanoma
Chromosomes
p16 Genes
Cell Cycle Proteins
Neoplasm Genes
Genetic Markers
Genes
Leukemia
Genome

ASJC Scopus subject areas

  • Surgery

Cite this

Nelson, M. A., Thompson, F. H., Emerson, J., Aickin, M., Adair, L., Trent, J. M., ... Taetle, R. (1996). Clinical implications of cytogenetic abnormalities in melanoma. Surgical Clinics of North America, 76(6), 1257-1271. https://doi.org/10.1016/S0039-6109(05)70513-2

Clinical implications of cytogenetic abnormalities in melanoma. / Nelson, Mark A; Thompson, F. H.; Emerson, J.; Aickin, M.; Adair, L.; Trent, J. M.; Leong, S. P L; Taetle, R.

In: Surgical Clinics of North America, Vol. 76, No. 6, 1996, p. 1257-1271.

Research output: Contribution to journalArticle

Nelson, MA, Thompson, FH, Emerson, J, Aickin, M, Adair, L, Trent, JM, Leong, SPL & Taetle, R 1996, 'Clinical implications of cytogenetic abnormalities in melanoma', Surgical Clinics of North America, vol. 76, no. 6, pp. 1257-1271. https://doi.org/10.1016/S0039-6109(05)70513-2
Nelson, Mark A ; Thompson, F. H. ; Emerson, J. ; Aickin, M. ; Adair, L. ; Trent, J. M. ; Leong, S. P L ; Taetle, R. / Clinical implications of cytogenetic abnormalities in melanoma. In: Surgical Clinics of North America. 1996 ; Vol. 76, No. 6. pp. 1257-1271.
@article{c945a11011944c49b2b08b9c2947c5bd,
title = "Clinical implications of cytogenetic abnormalities in melanoma",
abstract = "Unlike leukemia, in which specific reciprocal translocations are frequently observed, melanomas involve complex recurring chromosome anomalies. Analysis of the constituted genome of melanoma patients should identify cancer susceptibility genes and at-risk individuals in families with a history of melanoma. The first of these genes to be cloned is the cell cycle regulatory protein inhibitor-the p16 gene-and a second gene locus for melanoma predisposition has been linked to the chromosome 1p36 band region. Detection of the most common somatic genetic alterations in melanoma enhances our understanding of molecular mechanisms of melanoma development and may lead to genetic markers in melanoma. Some alterations may be used to identify interesting subpopulations. Others may be of prognostic value when they are considered in tandem with clinical data.",
author = "Nelson, {Mark A} and Thompson, {F. H.} and J. Emerson and M. Aickin and L. Adair and Trent, {J. M.} and Leong, {S. P L} and R. Taetle",
year = "1996",
doi = "10.1016/S0039-6109(05)70513-2",
language = "English (US)",
volume = "76",
pages = "1257--1271",
journal = "Surgical Clinics of North America",
issn = "0039-6109",
publisher = "W.B. Saunders Ltd",
number = "6",

}

TY - JOUR

T1 - Clinical implications of cytogenetic abnormalities in melanoma

AU - Nelson, Mark A

AU - Thompson, F. H.

AU - Emerson, J.

AU - Aickin, M.

AU - Adair, L.

AU - Trent, J. M.

AU - Leong, S. P L

AU - Taetle, R.

PY - 1996

Y1 - 1996

N2 - Unlike leukemia, in which specific reciprocal translocations are frequently observed, melanomas involve complex recurring chromosome anomalies. Analysis of the constituted genome of melanoma patients should identify cancer susceptibility genes and at-risk individuals in families with a history of melanoma. The first of these genes to be cloned is the cell cycle regulatory protein inhibitor-the p16 gene-and a second gene locus for melanoma predisposition has been linked to the chromosome 1p36 band region. Detection of the most common somatic genetic alterations in melanoma enhances our understanding of molecular mechanisms of melanoma development and may lead to genetic markers in melanoma. Some alterations may be used to identify interesting subpopulations. Others may be of prognostic value when they are considered in tandem with clinical data.

AB - Unlike leukemia, in which specific reciprocal translocations are frequently observed, melanomas involve complex recurring chromosome anomalies. Analysis of the constituted genome of melanoma patients should identify cancer susceptibility genes and at-risk individuals in families with a history of melanoma. The first of these genes to be cloned is the cell cycle regulatory protein inhibitor-the p16 gene-and a second gene locus for melanoma predisposition has been linked to the chromosome 1p36 band region. Detection of the most common somatic genetic alterations in melanoma enhances our understanding of molecular mechanisms of melanoma development and may lead to genetic markers in melanoma. Some alterations may be used to identify interesting subpopulations. Others may be of prognostic value when they are considered in tandem with clinical data.

UR - http://www.scopus.com/inward/record.url?scp=0030447607&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030447607&partnerID=8YFLogxK

U2 - 10.1016/S0039-6109(05)70513-2

DO - 10.1016/S0039-6109(05)70513-2

M3 - Article

C2 - 8977549

AN - SCOPUS:0030447607

VL - 76

SP - 1257

EP - 1271

JO - Surgical Clinics of North America

JF - Surgical Clinics of North America

SN - 0039-6109

IS - 6

ER -